144 related articles for article (PubMed ID: 14562419)
1. Liver cell adenoma with malignant transformation: a case report.
Ito M; Sasaki M; Wen CY; Nakashima M; Ueki T; Ishibashi H; Yano M; Kage M; Kojiro M
World J Gastroenterol; 2003 Oct; 9(10):2379-81. PubMed ID: 14562419
[TBL] [Abstract][Full Text] [Related]
2. Liver cell adenoma in a young man with elevated serum PIVKA-II level.
Uto H; Shigehira M; Kawano T; Nagatomo H; Kuribayashi T; Taniguchi S; Koga K; Komada N; Kitamura T; Maruyama T; Tsubouchi H
J Gastroenterol; 1996 Jun; 31(3):441-5. PubMed ID: 8726839
[TBL] [Abstract][Full Text] [Related]
3. Unclassified hepatocellular adenoma with histological brown pigment deposition and serum PIVKA-II level elevation: a case report.
Hoshino K; Harimoto N; Muranushi R; Hagiwara K; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Watanabe A; Kubo N; Araki K; Tomomasa R; Nobusawa S; Aishima S; Nakashima O; Shirabe K
Surg Case Rep; 2020 May; 6(1):94. PubMed ID: 32382834
[TBL] [Abstract][Full Text] [Related]
4. [A rare form of benign tumor of the liver possibly related to the use of oral contraceptives: focal pediculated nodular hyperplasia].
Brouquet J; Chameaud J; Vire O; Fabre P; Catanzano G; Baudet JH
Rev Fr Gynecol Obstet; 1985; 80(8-9):621-7. PubMed ID: 2997901
[TBL] [Abstract][Full Text] [Related]
5. Hepatic adenoma and focal nodular hyperplasia.
Shortell CK; Schwartz SI
Surg Gynecol Obstet; 1991 Nov; 173(5):426-31. PubMed ID: 1658955
[TBL] [Abstract][Full Text] [Related]
6. [Transformation of hepatic adenoma into hepatocellular carcinoma in patients with prolonged use of oral contraceptives].
Herman P; Machado MA; Volpe P; Pugliese V; Vianna MR; Bacchella T; Machado MC; Pinotti HW
Rev Hosp Clin Fac Med Sao Paulo; 1994; 49(1):30-3. PubMed ID: 8029613
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular adenoma. Its transformation to carcinoma in a user of oral contraceptives.
Tesluk H; Lawrie J
Arch Pathol Lab Med; 1981 Jun; 105(6):296-9. PubMed ID: 6263214
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of PIVKA-II in the detection of hepatocellular carcinoma based on real-world clinical data.
Yu R; Tan Z; Xiang X; Dan Y; Deng G
BMC Cancer; 2017 Sep; 17(1):608. PubMed ID: 28863782
[TBL] [Abstract][Full Text] [Related]
9. Oral contraceptive-associated liver cell adenoma and hepatocellular carcinoma. Cytomorphology and mechanism of malignant transformation.
Tao LC
Cancer; 1991 Jul; 68(2):341-7. PubMed ID: 1712664
[TBL] [Abstract][Full Text] [Related]
10. Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma.
Fujioka M; Nakashima Y; Nakashima O; Kojiro M
Hepatology; 2001 Dec; 34(6):1128-34. PubMed ID: 11732002
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma coexisting with hepatic adenoma. Incidental discovery after long-term oral contraceptive use.
Korula J; Yellin A; Kanel G; Campofiori G; Nichols P
West J Med; 1991 Oct; 155(4):416-8. PubMed ID: 1663298
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of plasma abnormal prothrombin (PIVKA-II) in patients with hepatocellular carcinoma.
Fujiyama S; Morishita T; Sagara K; Sato T; Motohara K; Matsuda I
Hepatogastroenterology; 1986 Oct; 33(5):201-5. PubMed ID: 2433199
[TBL] [Abstract][Full Text] [Related]
13. Malignant transformation of hepatocellular adenoma: report of a case.
Mouhoub M; Miry A; Haloui A; Karich N; Kamaoui I; Soufi M; Bennani A
Pan Afr Med J; 2020; 35():92. PubMed ID: 32636990
[TBL] [Abstract][Full Text] [Related]
14. Case of clear-cell hepatocellular carcinoma that developed in the normal liver of a middle-aged woman.
Takahashi A; Saito H; Kanno Y; Abe K; Yokokawa J; Irisawa A; Kenjo A; Saito T; Gotoh M; Ohira H
World J Gastroenterol; 2008 Jan; 14(1):129-31. PubMed ID: 18176975
[TBL] [Abstract][Full Text] [Related]
15. Liver cell adenoma with concomitant hepatocellular carcinoma: report of two cases.
Chuang WY; Chen TC; Hsu HL; Lee WC; Jeng LB; Huang SF
J Formos Med Assoc; 2002 Nov; 101(11):798-802. PubMed ID: 12517062
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous regression of hepatocellular carcinoma--a case report.
Matsuo R; Ogata H; Tsuji H; Kitazono T; Shimada M; Taguchi K; Fujishima M
Hepatogastroenterology; 2001; 48(42):1740-2. PubMed ID: 11813613
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory Hepatocellular Adenoma with Elevated Serum Protein Induced by Vitamin K Absence/Antagonist-II in Adult Males.
Koya Y; Suzuki T; Tai M; Ichii O; Matsuhashi N; Ejiri Y; Miyazawa M; Shibata M; Harada M; Kumabe T; Nakashima O
Intern Med; 2019 Jun; 58(12):1739-1746. PubMed ID: 30799343
[TBL] [Abstract][Full Text] [Related]
18. The malignant transformation of liver cell adenomas.
Foster JH; Berman MM
Arch Surg; 1994 Jul; 129(7):712-7. PubMed ID: 7517661
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular adenoma with malignant alteration.
Colovic R; Grubor N; Micev M; Radak V
Hepatogastroenterology; 2007 Mar; 54(74):386-8. PubMed ID: 17523280
[TBL] [Abstract][Full Text] [Related]
20. Malignant transformation of a β-catenin inflammatory adenoma due to an S45 β-catenin-activating mutation present 12 years before.
Sempoux C; Bisig B; Couchy G; Balabaud C; Zucman-Rossi J; Bioulac-Sage P
Hum Pathol; 2017 Apr; 62():122-125. PubMed ID: 27984126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
